Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arie Roth

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Experimental and Molecular Pathology|May 6, 2004
The effect of early and late treatment with the tyrphostin AG-556 on the progression of experimental autoimmune myocarditisJacob George, Iris Barshack, Iris Goldberg, et al.
The American Journal of Cardiology|April 9, 2013
Comparison of C-reactive protein and fibrinogen levels in patients having anterior wall ST-Segment elevation myocardial infarction with versus without left ventricular thrombus (from a primary percutaneous coronary intervention cohort)Yacov Shacham, Eran Leshem-Rubinow, Eyal Ben Assa, et al.
Cardiorenal Medicine|July 22, 2015
Admission Glucose Levels and the Risk of Acute Kidney Injury in Nondiabetic ST Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary InterventionYacov Shacham, Amir Gal-Oz, Eran Leshem-Rubinow, et al.
The Canadian Journal of Cardiology|July 12, 2015
Acute Cardio-Renal Syndrome as a Cause for Renal Deterioration Among Myocardial Infarction Patients Treated With Primary Percutaneous InterventionYacov Shacham, Eran Leshem-Rubinow, Amir Gal-Oz, et al.
Journal of the American College of Cardiology|April 6, 2005
The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosisYoav Michowitz, Emil Goldstein, Arie Roth, et al.
Atherosclerosis|May 12, 2004
L-arginine attenuates lymphocyte activation and anti-oxidized LDL antibody levels in patients undergoing angioplastyJacob George, Sigal Ben Shmuel, Arie Roth, et al.
The American Journal of Cardiology|December 6, 2014
Association of left ventricular function and acute kidney injury among ST-elevation myocardial infarction patients treated by primary percutaneous interventionYacov Shacham, Eran Leshem-Rubinow, Amir Gal-Oz, et al.
The Canadian Journal of Cardiology|December 31, 2014
Association of admission hemoglobin levels and acute kidney injury among myocardial infarction patients treated with primary percutaneous interventionYacov Shacham, Amir Gal-Oz, Eran Leshem-Rubinow, et al.
The American Journal of Cardiology|March 30, 2010
Effect of narcotic treatment on outcomes of acute coronary syndromesZaza Iakobishvili, Avital Porter, Alexander Battler, et al.
The American Journal of Cardiology|May 6, 2014
Comparison of left ventricular function following first ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention in men versus womenYacov Shacham, Yan Topilsky, Eran Leshem-Rubinow, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Experimental and Molecular Pathology|May 6, 2004
The effect of early and late treatment with the tyrphostin AG-556 on the progression of experimental autoimmune myocarditisJacob George, Iris Barshack, Iris Goldberg, et al.
The American Journal of Cardiology|April 9, 2013
Comparison of C-reactive protein and fibrinogen levels in patients having anterior wall ST-Segment elevation myocardial infarction with versus without left ventricular thrombus (from a primary percutaneous coronary intervention cohort)Yacov Shacham, Eran Leshem-Rubinow, Eyal Ben Assa, et al.
Cardiorenal Medicine|July 22, 2015
Admission Glucose Levels and the Risk of Acute Kidney Injury in Nondiabetic ST Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary InterventionYacov Shacham, Amir Gal-Oz, Eran Leshem-Rubinow, et al.
The Canadian Journal of Cardiology|July 12, 2015
Acute Cardio-Renal Syndrome as a Cause for Renal Deterioration Among Myocardial Infarction Patients Treated With Primary Percutaneous InterventionYacov Shacham, Eran Leshem-Rubinow, Amir Gal-Oz, et al.
Journal of the American College of Cardiology|April 6, 2005
The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosisYoav Michowitz, Emil Goldstein, Arie Roth, et al.
Atherosclerosis|May 12, 2004
L-arginine attenuates lymphocyte activation and anti-oxidized LDL antibody levels in patients undergoing angioplastyJacob George, Sigal Ben Shmuel, Arie Roth, et al.
The American Journal of Cardiology|December 6, 2014
Association of left ventricular function and acute kidney injury among ST-elevation myocardial infarction patients treated by primary percutaneous interventionYacov Shacham, Eran Leshem-Rubinow, Amir Gal-Oz, et al.
The Canadian Journal of Cardiology|December 31, 2014
Association of admission hemoglobin levels and acute kidney injury among myocardial infarction patients treated with primary percutaneous interventionYacov Shacham, Amir Gal-Oz, Eran Leshem-Rubinow, et al.
The American Journal of Cardiology|March 30, 2010
Effect of narcotic treatment on outcomes of acute coronary syndromesZaza Iakobishvili, Avital Porter, Alexander Battler, et al.
The American Journal of Cardiology|May 6, 2014
Comparison of left ventricular function following first ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention in men versus womenYacov Shacham, Yan Topilsky, Eran Leshem-Rubinow, et al.
Pageof 8